Amazon Recalls 113,000 Bottles of Pain Relievers Over Discoloration Concerns

Amazon recalls 113k pain reliever bottles due to discoloration. Check your cabinets and verify lot numbers.

October 14, 2026 One Min Read

POLICY WIRE — City, Country — Amazon has issued a voluntary recall of over 112,000 bottles of its branded pain relievers after reports of discolored tablets surfaced.

The U.S. Food and Drug Administration confirmed the action in an enforcement report, noting that specific batches of Amazon Basic Care Extra Strength Pain Relief acetaminophen 500mg caplets are affected. The move followed customer complaints about tablet discoloration, prompting the company to act in coordination with manufacturer Aurohealth and the FDA.

📖 THE POLICY DIGEST MAGAZINE: OCTOBER 2026 EDITION NOW LIVE

Exclusive Battle Damage Assessment by Sarah Adams, US-Iran Diplomatic Talks & Transnational Investigations

👉 READ BY CLICKING HERE

The recall includes 90,456 500-count bottles, 14,640 200-count bottles, and 7,836 1000-count bottles, all with varying lot numbers and expiration dates ranging from September 30, 2027, to February 29, 2028. No health incidents have been reported, and Amazon is reaching out to customers who purchased the affected products for refunds.

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.